Drug intelligence / Profile preview

penicillin G benzathine + penicillin G procaine

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Penicillin G benzathine + penicillin G procaine is a combination injectable suspension containing two long-acting forms of penicillin G: **benzathine** and **procaine** salts. This formulation is administered by deep intramuscular injection and is designed to provide both sustained and intermediate levels of penicillin G for effective antibacterial activity while reducing injection site discomfort compared to benzathine penicillin G alone[5][6]. The combination acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), resulting in bacterial cell death. It is primarily indicated for treatment of moderately severe infections caused by susceptible strains of streptococci (such as Streptococcus pyogenes) and pneumococci (Streptococcus pneumoniae), including streptococcal pharyngitis, upper respiratory tract infections, and as prophylaxis against rheumatic fever. This formulation is **not approved for treatment of venereal diseases such as syphilis or gonorrhea**. Patients with a history of hypersensitivity to penicillins or to procaine should not receive this combination[5][6].

Brand names
Bicillin C-RBicillin C-R 900/300Bicillin C-R 600/600
Other names
penicillin G benzathine and penicillin G procainebenzylpenicillin benzathine and benzylpenicillin procainepenicillin G benzathine + penicillin G procaine injectable suspension
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on penicillin G benzathine + penicillin G procaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on penicillin G benzathine + penicillin G procaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call